COST Days sales outstanding
Days sales outstanding at Costco rose to 4.2 days in fiscal 2025, the highest in the 5 years reported, from 3.9 days in 2024.
Year-end receivables divided by total revenue, times 365. Both inputs as filed.
SOURCE: us-gaap:ReceivablesNetCurrent + us-gaap:Revenues · EDGAR CompanyFacts · CIK 909832 · EDGAR ↗ · FY2021–FY2025 · ANNUAL
History AS FILED · DERIVATION SHOWN WHERE DERIVED
| Fiscal year | Receivables | Revenue | DSO |
|---|---|---|---|
| FY2025 | $3.2B | $275.2B | 4.2 days |
| FY2024 | $2.7B | $254.5B | 3.9 days |
| FY2023 | $2.3B | $242.3B | 3.4 days |
| FY2022 | $2.2B | $227.0B | 3.6 days |
| FY2021 | $1.8B | $195.9B | 3.4 days |
Cross-checks touching this measure FROM THE FILING REVIEW
◐ PARTLYgasoline sales mix
The quoted figures do not map one-for-one onto a filed line on this page; carried as partly supported.
FY2025 10-K · FULL RECONCILIATION →◐ PARTLYe-commerce sales mix
The quoted figures do not map one-for-one onto a filed line on this page; carried as partly supported.
FY2025 10-K · FULL RECONCILIATION →◐ PARTLYExecutive member penetration
The quoted figures do not map one-for-one onto a filed line on this page; carried as partly supported.
FY2025 10-K · FULL RECONCILIATION →◐ PARTLYUS/Canada concentration
The quoted figures do not map one-for-one onto a filed line on this page; carried as partly supported.
FY2025 10-K · FULL RECONCILIATION →◐ PARTLYinternational segment mix
The quoted figures do not map one-for-one onto a filed line on this page; carried as partly supported.
FY2025 10-K · FULL RECONCILIATION →✓ CLEANReceivables pace
Days sales outstanding moved +0.3 days — inside the ±7-day watch threshold.
FY2025 10-K · FULL RECONCILIATION →✓ CLEANInventory vs revenue pace
Inventory moved -2.8%, revenue +8.2% (gap -11.0pp). The flag tests inventory OUTRUNNING revenue by more than 7pp.
FY2025 10-K · FULL RECONCILIATION →More SAME DATA, OTHER VIEWS
Days sales outstanding across coverage → · COST company view →
Revenue · Net income · Operating cash flow · Free cash flow · Capital expenditure · Cash & equivalents · Total assets · Shareholders' equity · Total debt · Return on equity
Not investment advice. Every figure on this page is an XBRL fact from the issuer's own SEC filings or an arithmetic over such facts with the method shown. No forecast is made; no posture is expressed.